A look at the top medical headlines for the week of May 10, 2020 including: A number of new treatments for COVID-19 are showing promise and could be fast-tracked if clinical trials continue to show good results. Then, another trial of 53 severely ill patients reported in the New England Journal of Medicine found that 68 percent showed clinical improvement with Remdesivir. Then, viruses like COVID-19 that jump from animals to people are going to become more common. Then, If you’re having trouble sleeping these days, you’re far from alone. And finally many people are concerned about getting COVID-19 from food they buy, but scientists say the risk of that is very, very low.
A look at the top medical headlines for the week of April 19, 2020 including: If you’ve been taking the drug Ranitidine for reflux or ulcer prevention, the FDA says stop. Then, a new study shows that parents are yelling at their children more since most of us have been ordered to stay home. And finally, with COVID-19 testing in such short supply… why not let a dog do it?
A look at the top medical headlines for the week of November 17, 2019.
A look at the top medical headlines for the week of July 28, 2019.
Suddenly, cannabis-related, hemp-derived CBD is almost everywhere. CBD’s FDA status is murky, and we know very little about its benefits, thanks in part to its former place on DEA Schedule 1. How much has been proven about its supposed health qualities? What are the risks? Experts discuss in depth.
Since the 1980’s, almost all production of generic drugs has moved overseas, where FDA inspectors have a much tougher time making sure they’re following rules for safety. An investigative journalist describes the ways she’s found that many drugmakers cut corners, putting safety at risk, and details what consumers can do to protect themselves.
A look at the top medical headlines for the week of March 31, 2019.
Experts explain the FDA's proposed plan to mandate a significant cut in the nicotine content of cigarettes to encourage them to move to healthier forms of nicotine distribution.
Some FDA commissioner candidates have proposed radical reform. Experts discuss what reform might look like and what the FDA needs to better succeed.